Moreover, RRAS2 overexpression was found to be higher in patients with full-blown CLL than in patients with the pre-malignant stage monoclonal B-cell lymphocytosis (MBL). This evidence concerns the gene RRAS2 and B-cell chronic lymphocytic leukemia.